Why Bioavailability Matters

A talk by Catherine Harvey
Director of Operations, Satipharm

Register to watch this content

By submitting your email you agree to the terms
Watch this content now

About this talk

In this presentation, Catherine Harvey, Director of Operations at Satipharm explains why bioavailability matters when treating patients with medical cannabis.

Proudly supported by

Want to sponsor? Contact us to find out more.